nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0629	0.0934	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.0493	0.0733	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.0316	0.047	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.0316	0.047	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0294	0.0437	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0252	0.0374	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0252	0.0374	CbGpPWpGaD
Bisacodyl—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0238	0.0727	CcSEcCtD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0234	0.0348	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0227	0.0337	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0194	0.0288	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0192	0.0285	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0192	0.0285	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0184	0.0273	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0178	0.0265	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0173	0.0256	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.0171	0.0255	CbGpPWpGaD
Bisacodyl—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0153	0.0467	CcSEcCtD
Bisacodyl—GPR55—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0147	0.0219	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.014	0.0208	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0136	0.0202	CbGpPWpGaD
Bisacodyl—Dehydration—Furosemide—dilated cardiomyopathy	0.0134	0.0408	CcSEcCtD
Bisacodyl—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.013	0.0397	CcSEcCtD
Bisacodyl—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0129	0.0395	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0112	0.0342	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0108	0.0161	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0108	0.0161	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0104	0.0154	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0101	0.015	CbGpPWpGaD
Bisacodyl—Dehydration—Lisinopril—dilated cardiomyopathy	0.01	0.0306	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00983	0.0146	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00983	0.0146	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00975	0.0145	CbGpPWpGaD
Bisacodyl—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00971	0.0297	CcSEcCtD
Bisacodyl—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00956	0.0292	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00914	0.0136	CbGpPWpGaD
Bisacodyl—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00898	0.0274	CcSEcCtD
Bisacodyl—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00888	0.0271	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00885	0.0132	CbGpPWpGaD
Bisacodyl—Malnutrition—Furosemide—dilated cardiomyopathy	0.00865	0.0264	CcSEcCtD
Bisacodyl—Dizziness—Spironolactone—dilated cardiomyopathy	0.00858	0.0262	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00833	0.0124	CbGpPWpGaD
Bisacodyl—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00832	0.0254	CcSEcCtD
Bisacodyl—Vomiting—Spironolactone—dilated cardiomyopathy	0.00825	0.0252	CcSEcCtD
Bisacodyl—Headache—Spironolactone—dilated cardiomyopathy	0.00813	0.0249	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.0079	0.0117	CbGpPWpGaD
Bisacodyl—Nausea—Spironolactone—dilated cardiomyopathy	0.00771	0.0236	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00756	0.0112	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00717	0.0107	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00706	0.0216	CcSEcCtD
Bisacodyl—Shock—Furosemide—dilated cardiomyopathy	0.00695	0.0212	CcSEcCtD
Bisacodyl—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00693	0.0212	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00654	0.00973	CbGpPWpGaD
Bisacodyl—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00649	0.0198	CcSEcCtD
Bisacodyl—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00624	0.0191	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00613	0.00912	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0061	0.0186	CcSEcCtD
Bisacodyl—Angioedema—Lisinopril—dilated cardiomyopathy	0.00593	0.0181	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00586	0.00871	CbGpPWpGaD
Bisacodyl—Syncope—Lisinopril—dilated cardiomyopathy	0.00582	0.0178	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00581	0.00864	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00581	0.00864	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00578	0.0176	CcSEcCtD
Bisacodyl—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00571	0.0174	CcSEcCtD
Bisacodyl—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00558	0.0171	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00557	0.00828	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.0054	0.00803	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00532	0.00791	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.0053	0.0162	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00523	0.00777	CbGpPWpGaD
Bisacodyl—Shock—Lisinopril—dilated cardiomyopathy	0.00521	0.0159	CcSEcCtD
Bisacodyl—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0052	0.0159	CcSEcCtD
Bisacodyl—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00483	0.0148	CcSEcCtD
Bisacodyl—Dizziness—Furosemide—dilated cardiomyopathy	0.00467	0.0143	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00458	0.014	CcSEcCtD
Bisacodyl—Vomiting—Furosemide—dilated cardiomyopathy	0.00449	0.0137	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00447	0.00664	CbGpPWpGaD
Bisacodyl—Headache—Furosemide—dilated cardiomyopathy	0.00442	0.0135	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00433	0.0132	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00424	0.0063	CbGpPWpGaD
Bisacodyl—Nausea—Furosemide—dilated cardiomyopathy	0.0042	0.0128	CcSEcCtD
Bisacodyl—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00419	0.0128	CcSEcCtD
Bisacodyl—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0039	0.0119	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00369	0.00549	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00364	0.00541	CbGpPWpGaD
Bisacodyl—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00363	0.0111	CcSEcCtD
Bisacodyl—Dizziness—Lisinopril—dilated cardiomyopathy	0.0035	0.0107	CcSEcCtD
Bisacodyl—Vomiting—Lisinopril—dilated cardiomyopathy	0.00337	0.0103	CcSEcCtD
Bisacodyl—Headache—Lisinopril—dilated cardiomyopathy	0.00332	0.0101	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00329	0.00489	CbGpPWpGaD
Bisacodyl—Nausea—Lisinopril—dilated cardiomyopathy	0.00315	0.00962	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—AGT—dilated cardiomyopathy	0.00314	0.00467	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00253	0.00376	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00218	0.00324	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—EGFR—dilated cardiomyopathy	0.0015	0.00222	CbGpPWpGaD
